Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet
NCT ID: NCT00827450
Last Updated: 2012-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2009-02-28
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans
* whether the protective effect of coffee is dependent on it's antioxidant composition
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coffee Effect in HCV-related Hepatitis
NCT01572103
Coffee Consumption and NASH in the French Population.
NCT03432377
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932
Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
NCT00844779
Prospective Cohort Study in Patients With NAFLD
NCT00575133
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to evaluate whether coffee prevents hepatic lipid deposition in healthy male subjects fed a fructose-rich hypercaloric diet. Both caffeine and antioxidants (yet unspecified) may be involved.. To sort out the role of caffeine and antioxidants, we will test 3 different soluble coffee, ie fully torrefied decaffeinated coffee , partially torrefied decaffeinated coffee, and partially torrefied caffeinated coffee.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ctl
control isocaloric diet; no coffee
Ctl
Control, isocaloric diet; no coffee
HF
Hypercaloric. high fructose diet; no coffee
High fructose diet; no coffee
Hypercaloric, high fructose diet; no coffee
C1
Hypercaloric, high fructose diet; caffeine-free, torrefied coffee
fully torrefied, caffeine-free coffee
Hypercaloric, high fructose diet + coffee
C2
Hypercaloric, high fructose diet; caffeine-free, partially torrefied coffee
partially torrefied, caffeine-free coffee
Hypercaloric, high fructose diet + coffee
C3
Hypercaloric, high fructose diet; caffeinated, partially torrefied coffee
Partially torrefied, caffeinated coffee
Hypercaloric, high fructose diet + coffee
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ctl
Control, isocaloric diet; no coffee
High fructose diet; no coffee
Hypercaloric, high fructose diet; no coffee
fully torrefied, caffeine-free coffee
Hypercaloric, high fructose diet + coffee
partially torrefied, caffeine-free coffee
Hypercaloric, high fructose diet + coffee
Partially torrefied, caffeinated coffee
Hypercaloric, high fructose diet + coffee
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* less than 30 min physical activity /day
* habitual coffee consumption less than three cupy /day
* consumption of caffeine-containing sodas less than 2 servings/day
* non-smoker
Exclusion Criteria
* presence of metallic foreign bodies
* history of eye surgery
* family history of diabetes mellitus
* history of food intolerance
* vegetarians
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nestlé Research Center, Vers-chez-les-blanc, Switzerland
UNKNOWN
University of Lausanne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luc Tappy, MD
professor of physiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luc Tappy, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Physiology, University of Lausanne, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre d'investigations cliniques "cardiomet"/ CHUV
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lecoultre V, Carrel G, Egli L, Binnert C, Boss A, MacMillan EL, Kreis R, Boesch C, Darimont C, Tappy L. Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men. Am J Clin Nutr. 2014 Feb;99(2):268-75. doi: 10.3945/ajcn.113.069526. Epub 2013 Nov 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COLIBRI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.